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Abstract 
The term orofacial granulomatosis (OFG) is a descriptive term used for granulomatous disorders affecting the face 
and oral cavity, which can occur for a variety of reasons resulting in significant morbidity. It is characterised by 
persistent swelling that may involve one or both the lips and /or recurrent ulcers and a variety of other orofacial 
features. Medical history is very important in the diagnosis of OFG as medical condition like Crohn’s disease can 
also present an extra intestinal manifestation of OFG. Exclusion of other entities like sarcoidosis, mycobacterial 
infections, foreign body reactions and biopsy helps to establish a correct diagnosis. Herein we report a case of OFG 
in a 55 year old female patient with review of literature. 
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Introduction
Wiesenfeld (1) in 1985 introduced OFG and since then it 
has been a well accepted and unifying term assembling a 
variety of clinical presentations that on histopathological 
examination reveal the presence of nonspecific granu-
lomatous inflammation. It is a nonspecific, descriptive 
term encompassing a variety of conditions that exhibit 
similar clinical and microscopic features. If all possible 
causes have been ruled out, OFG is used as a clinical 
diagnosis of exclusion (2).The clinical presentation 
of OFG is highly variable, the most consistent finding 
being persistent, painless swelling of the orofacial tis-
sues. Lips are the most frequent site of involvement and 
other intraoral sites commonly affected are the tongue, 
gingiva and buccal mucosa. OFG is a non life threate-
ning disease of unknown etiology that may need further 
clinical, hematological, radiographic and endoscopic 
investigation to arrive at a correct diagnosis. Cheilitis 
granulomatosa is a subtype of OFG in which there is 
persistent, nontender swelling restricted to one or both 
the lips (3). Early diagnosis is important as it provides 
better prognosis. The first goal of management should be 
identification of the initiating cause, however this can be 
difficult as often the reason is elusive at times and there 
can be spontaneous remission in a few cases.
Case report   
A 55-year-old female patient reported with a complaint 
of swelling of her upper and lower lips since 2 years 
and gingival enlargement since 8 months. Her past den-
tal history revealed extraction of maxillary anterior teeth 
because of mobility and gingival enlargement. There was 
no contributory medical history, drug use and family bac-
kground. Extraoral examination revealed diffuse enlar-
gement of the right and left cheeks, and upper and lower 
lips. The swelling of the cheek was firm and indurated. 
The contour of the upper and lower lips was lost, were 
inflamed, everted, fissured and crustated (Fig.1). On pal-
pation the upper and lower lips were firm in consistency 
and non tender. Intraoral examination revealed gingival 
enlargement of the maxillary and mandibular arches 
(Fig.2). Marginal, interdental and attached gingiva was 
enlarged and only the incisal edges of the mandibular 
incisors were visible whereas half of the maxillary pre-
molar and molar teeth were covered by gingiva (Fig.3). 
Fig. 1. Enlargement of the cheeks, upper and lower lips. The lips are 
inflamed and lower lip is everted 
Fig. 2. Enlarged gingiva irt maxillary premolar and molar region 
covering half of the crowns.
Fig. 3. Enlarged gingiva irt mandibular teeth covering 2/3 rd of the 
crowns with cobble stone appearance of lower labial mucosa.
The gingiva was inflamed, soft in consistency, non ten-
der and no bleeding on probing was present. The lower 
labial mucosa showed cobble stone appearance (Fig.3). 
Hard tissue examination revealed few missing teeth, ge-
neralized attrition and grade I mobility of all mandibular 
anterior teeth. Angioneurotic edema, Crohn’s disease, 
sarcoidosis, tuberculosis and cheilitis granulomatosa 
were considered under differential diagnosis. 
Incisional biopsy from the lower labial mucosa was per-
formed and histopathological examination revealed the 
presence of non caseating granulomas composed of epi-
theloid histiocytes and giant cells with a peripheral rim 
of lymphocytes. Routine hematological and biochemical 
investigations were done (Table 1). On endoscopic exa-
mination to rule out Crohn’s disease, the intestinal mu-
cosa appeared normal with no erythema or ulcerations. 
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thesia may be present. The involved buccal and labial 
mucosa show cobble stone appearance. Gingival swe-
lling and tenderness may be present (1). Mignogna etal 
(8) reported a monosymptomatic onset with generalized 
hyperplastic gingivitis that preceded other facial and 
mucosal lesions.
As the clinical and histopathological features of OFG 
can be produced by a variety of underlying causes the 
patient should be evaluated for other granulomatous 
conditions like Crohn’s disease, sarcoidosis, mycobac-
terial infection (tuberculosis, leprosy, and atypical my-
cobacterium), foreign body reaction and contact allergy 
(2). IgE levels and patch test may be of diagnostic value 
when hypersensitivity reaction is suspected. Exclusion 
of sarcoidosis can be done by chest radiograph, serum 
angiotensinogen converting enzyme level and eventua-
lly Kveim test. Tuberculosis should be ruled out by acid 
fast bacillus staining and chest radiographs. 10%- 37% 
of patients with OFG have been found to have Crohn’s 
disease and oral lesions may precede the intestinal in-
volvement (8). Hence, endoscopy and colorectal biopsy 
are justified when signs and symptoms of gastrointesti-
nal disturbance is observed. All the above investigations 
were carried out in our patient to rule out the above men-
tioned conditions. Histopathological examination shows 
chronic inflammatory cell infiltrate particularly peri and 
paravascular aggregation of lymphocytes, plasma cells, 
non caseating granuloma formations with epitheloid 
cells and Langhans type of giant cells. 
A variety of drugs have been tried in the treatment of 
OFG but the most preferred mode of treatment is sys-
temic corticosteroids. Glucocorticoids effectively su-
ppress the activated T- helper cell process occurring at 
The chest radiograph appeared normal. Patch testing 
was done for commonly used food products and cosme-
tics and the results were negative.
A diagnosis of OFG was made based on correlation of 
the histopathological and laboratory findings. The patient 
was treated with triamicinolone 40mg/ml intralesionaly 
twice a week for 4 weeks followed by slow tapering 
dose of 20 mg for 2 weeks, 10 mg for 2 weeks and then 
the drug was discontinued thereafter. Following this the-
re was considerable reduction in the size of the lips and 
cheeks at the end of 8 weeks. Subsequently, the patient 
is under follow up since 18 months and has shown no 
signs of recurrence. 
Discussion
OFG is an uncommon disease affecting the oral and pe-
rioral structures of the face. It is normally seen in the 
second decade of life and has a female predilection. 
Zimmer etal (4)  in a literature review of 262 patients 
reported a female predilection of 56%. The precise etio-
logy is unknown but a genetic predisposition may be 
possible (5). A cell mediated hypersensitivity reaction is 
predicted as an etiologic factor because of the presence 
of activated helper T lymphocytes expressing interleu-
kin-2 receptors in these lesions (6). It is also postulated 
that the cytokine production by lymphocytic clone could 
be responsible for the formation of granulomas in this 
condition (7). 
The clinical presentation of OFG is variable. The most 
frequent presentation is a nontender, persistent swelling 
involving one or both the lips. Rarely, superficial am-
ber vesicles resembling lymphangioma may be found. 
When the tongue is involved fissures, edema and pares-
Investigations Results Reference range
Haemoglobin
Total  WBC count
Neutrophils 
Eosinophils
Monocytes 
Lymphocytes 
Platelet count
Peripheral smear
ESR
11.2 gm/dl
9,300/mm3 
56%
4%
3%
35%
2,65,000 lakhs/mm3 
Normocytic normochromic
18mm/hr
14-16 gm/dl 
4000-11000/mm3 
 40- 74%
1-7 %
1-9 %
20-40 %
1.5-4lakhs /mm3 
10-20 mm/hr
AFB staining Negative
SACE level 52 u/ltr 5 - 89 u/ltr
WBC-White blood cells
ESR-Erythrocyte sedimentation rate
AFB-Acid fast staining bacilli
SACE – Serum angiotensinogen converting enzyme inhibitor
Table 1. Diagnostic workup in OFG
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the site of the disease. The usual therapy is prednisolone 
1mg/kg for 4-6 weeks followed by slow tapering over 
2-3 months. Sakuntabhai etal (9) suggested treatment 
with high volume of steroids of 3-10 ml, gave a disease 
free period of 10 months but the major disadvantage was 
the large volume which produced considerable pain and 
discomfort to the patient during the administration of the 
drug. In a pilot study conducted by Mignogna etal (10), 
small volume, high- concentration of extended release 
triamicinolone injection appeared to be effective. In our 
patient the intralesional use of high volume triamicino-
lone in a tapering dose over a period of eight weeks re-
sulted in resolution of the lesion with no recurrence du-
ring the follow up period of eighteen months. Drugs like 
salazosulfapyridine, hydroxychloroquine, azathioprine, 
dapsone, methotrexate and thalidomide have been tried 
with partial success. Surgical recontouring (reduction 
chiloplasty) is not frequently used as there is an increa-
sed risk of recurrence. Prognosis is variable and is best 
in early diagnosed cases (1).
Dentists are the first among health care professionals to 
be consulted for diagnosis and treatment of this disorder. 
Hence, the dentists should be familiar with all the pos-
sible granulomatous conditions affecting the orofacial 
region. 
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